(S)-nicotine increases expression ISO RGD:1354186 6480464 Nicotine results in increased expression of SLC7A5 mRNA CTD PMID:23825647 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1354186 6480464 o, p'-DDT results in increased expression of SLC7A5 mRNA CTD PMID:22609851 1,1-dichloroethene increases expression ISO RGD:733672 6480464 vinylidene chloride results in increased expression of SLC7A5 mRNA CTD PMID:26682919 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1354186 6480464 Dinitrochlorobenzene results in increased expression of SLC7A5 mRNA CTD PMID:17374397 17alpha-ethynylestradiol affects expression ISO RGD:1354186 6480464 Ethinyl Estradiol affects the expression of SLC7A5 mRNA CTD PMID:20170705 17alpha-ethynylestradiol increases expression ISO RGD:1354186 6480464 Ethinyl Estradiol results in increased expression of SLC7A5 mRNA CTD PMID:18936297 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC7A5 mRNA CTD PMID:20170705 17beta-estradiol decreases expression ISO RGD:1354186 6480464 Estradiol results in decreased expression of SLC7A5 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:1354186 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC7A5 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1354186 6480464 Estradiol results in increased expression of SLC7A5 mRNA CTD PMID:15757668 more ... 17beta-estradiol increases expression ISO RGD:733672 6480464 Estradiol results in increased expression of SLC7A5 mRNA CTD PMID:14664709 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:29142165 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:733672 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:29142165 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:733672 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:29142165 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1354186 6480464 [Tetrachlorodibenzodioxin co-treated with AHR mRNA] affects the expression of SLC7A5 mRNA, [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC7A5 mRNA CTD PMID:19684285 , PMID:20619336 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733672 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC7A5 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1354186 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC7A5 mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC7A5 mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1354186 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A5 mRNA CTD PMID:22298810 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SLC7A5 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1354186 6480464 beta-methylcholine affects the expression of SLC7A5 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1354186 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354186 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SLC7A5 mRNA CTD PMID:28628672 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1354186 6480464 Oxazolone results in increased expression of SLC7A5 mRNA CTD PMID:17374397 4-hydroxyphenyl retinamide increases expression ISO RGD:733672 6480464 Fenretinide results in increased expression of SLC7A5 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1354186 6480464 Fenretinide results in increased expression of SLC7A5 mRNA CTD PMID:15958647 5-aza-2'-deoxycytidine affects expression ISO RGD:1354186 6480464 Decitabine affects the expression of SLC7A5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC7A5 mRNA CTD PMID:24780913 , PMID:25825206 actinomycin D multiple interactions ISO RGD:1354186 6480464 Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of SLC7A5 mRNA] CTD PMID:26621329 afimoxifene increases expression ISO RGD:1354186 6480464 afimoxifene results in increased expression of SLC7A5 mRNA CTD PMID:19901195 aflatoxin B1 decreases expression ISO RGD:733672 6480464 Aflatoxin B1 results in decreased expression of SLC7A5 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1354186 6480464 Aflatoxin B1 results in decreased methylation of SLC7A5 intron CTD PMID:30157460 aflatoxin B2 decreases methylation ISO RGD:1354186 6480464 aflatoxin B2 results in decreased methylation of SLC7A5 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1354186 6480464 Tretinoin results in increased expression of SLC7A5 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:1354186 6480464 Tretinoin results in decreased expression of SLC7A5 mRNA CTD PMID:16054129 , PMID:23724009 AM-251 increases expression ISO RGD:1354186 6480464 AM 251 results in increased expression of SLC7A5 mRNA CTD PMID:16500647 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC7A5 mRNA CTD PMID:16483693 arsane affects methylation ISO RGD:1354186 6480464 Arsenic affects the methylation of SLC7A5 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1354186 6480464 Arsenic affects the methylation of SLC7A5 gene CTD PMID:25304211 atrazine decreases expression ISO RGD:1354186 6480464 Atrazine results in decreased expression of SLC7A5 mRNA CTD PMID:22378314 benzene increases expression ISO RGD:1354186 6480464 Benzene results in increased expression of SLC7A5 mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:733672 6480464 Benzo(a)pyrene results in decreased expression of SLC7A5 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene increases expression ISO RGD:1354186 6480464 Benzo(a)pyrene results in increased expression of SLC7A5 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:733672 6480464 Benzo(a)pyrene results in increased expression of SLC7A5 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1354186 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1354186 6480464 7 more ... CTD PMID:17944540 beta-naphthoflavone increases expression ISO RGD:1354186 6480464 beta-Naphthoflavone results in increased expression of SLC7A5 mRNA CTD PMID:19737606 bexarotene decreases expression ISO RGD:1354186 6480464 bexarotene results in decreased expression of SLC7A5 mRNA CTD PMID:17178900 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1354186 6480464 Diethylhexyl Phthalate results in increased expression of SLC7A5 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1354186 6480464 bisphenol A affects the expression of SLC7A5 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A increases methylation ISO RGD:733672 6480464 bisphenol A results in increased methylation of SLC7A5 promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC7A5 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC7A5 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1354186 6480464 bisphenol A results in decreased expression of SLC7A5 mRNA CTD PMID:25047013 , PMID:29718440 bisphenol A increases expression ISO RGD:1354186 6480464 bisphenol A results in increased expression of SLC7A5 mRNA CTD PMID:23019147 bortezomib decreases expression ISO RGD:1354186 6480464 Bortezomib results in decreased expression of SLC7A5 mRNA CTD PMID:20977926 butan-1-ol multiple interactions ISO RGD:1354186 6480464 [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC7A5 mRNA CTD PMID:29432896 cadmium dichloride increases expression ISO RGD:1354186 6480464 Cadmium Chloride results in increased expression of SLC7A5 mRNA CTD PMID:25596134 , PMID:26472689 cadmium dichloride decreases expression ISO RGD:1354186 6480464 Cadmium Chloride results in decreased expression of SLC7A5 mRNA CTD PMID:30998937 carbamazepine affects expression ISO RGD:1354186 6480464 Carbamazepine affects the expression of SLC7A5 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1354186 6480464 Nanotubes, Carbon analog results in increased expression of SLC7A5 mRNA CTD PMID:25102311 carbon nanotube increases expression ISO RGD:733672 6480464 Nanotubes, Carbon analog results in increased expression of SLC7A5 mRNA, Nanotubes, Carbon results in increased expression of SLC7A5 mRNA CTD PMID:25554681 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of SLC7A5 mRNA CTD PMID:19395590 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of SLC7A5 mRNA CTD PMID:18500788 chloroacetaldehyde affects expression ISO RGD:1354186 6480464 chloroacetaldehyde affects the expression of SLC7A5 mRNA CTD PMID:25596134 chloropicrin decreases expression ISO RGD:1354186 6480464 chloropicrin results in decreased expression of SLC7A5 mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:733672 6480464 Chloroprene results in increased expression of SLC7A5 mRNA CTD PMID:23125180 cholesterol increases expression ISO RGD:1354186 6480464 Cholesterol results in increased expression of SLC7A5 mRNA CTD PMID:26296894 chrysene increases expression ISO RGD:1354186 6480464 chrysene results in increased expression of SLC7A5 mRNA CTD PMID:26621329 cidofovir anhydrous increases expression ISO RGD:1354186 6480464 Cidofovir results in increased expression of SLC7A5 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1354186 6480464 Cisplatin results in decreased expression of SLC7A5 mRNA CTD PMID:27594783 cisplatin increases expression ISO RGD:1354186 6480464 Cisplatin results in increased expression of SLC7A5 mRNA CTD PMID:25596134 cisplatin affects expression ISO RGD:1354186 6480464 Cisplatin affects the expression of SLC7A5 mRNA CTD PMID:23300844 clobetasol increases expression ISO RGD:733672 6480464 Clobetasol results in increased expression of SLC7A5 mRNA CTD PMID:27462272 clodronic acid affects expression ISO RGD:1354186 6480464 Clodronic Acid affects the expression of SLC7A5 mRNA CTD PMID:25596134 clofibrate decreases expression ISO RGD:733672 6480464 Clofibrate results in decreased expression of SLC7A5 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1354186 6480464 cobaltous chloride results in decreased expression of SLC7A5 mRNA CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC7A5 mRNA CTD PMID:24386269 coumestrol multiple interactions ISO RGD:1354186 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1354186 6480464 Coumestrol results in increased expression of SLC7A5 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO RGD:1354186 6480464 Asbestos, Crocidolite affects the expression of SLC7A5 mRNA CTD PMID:25757056 cycloheximide multiple interactions ISO RGD:1354186 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC7A5 mRNA CTD PMID:19684285 cyclosporin A decreases expression ISO RGD:1354186 6480464 Cyclosporine results in decreased expression of SLC7A5 mRNA CTD PMID:25562108 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC7A5 mRNA CTD PMID:25596134 cyclosporin A increases expression ISO RGD:1354186 6480464 Cyclosporine results in increased expression of SLC7A5 mRNA CTD PMID:20106945 more ... daidzein increases expression ISO RGD:1354186 6480464 daidzein results in increased expression of SLC7A5 mRNA CTD PMID:15757668 dexamethasone decreases expression ISO RGD:733672 6480464 Dexamethasone results in decreased expression of SLC7A5 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1354186 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SLC7A5 mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:1354186 6480464 Dexamethasone results in decreased expression of SLC7A5 mRNA CTD PMID:25047013 dextran sulfate multiple interactions ISO RGD:733672 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC7A5 mRNA CTD PMID:29950665 dicrotophos increases expression ISO RGD:1354186 6480464 dicrotophos results in increased expression of SLC7A5 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:1354186 6480464 Diethylstilbestrol results in increased expression of SLC7A5 mRNA CTD PMID:19371625 , PMID:26865669 dioxygen increases expression ISO RGD:1354186 6480464 Oxygen deficiency results in increased expression of SLC7A5 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:733672 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A5 mRNA CTD PMID:30529165 dioxygen decreases expression ISO RGD:1354186 6480464 Oxygen deficiency results in decreased expression of SLC7A5 mRNA CTD PMID:26516004 disodium selenite increases expression ISO RGD:1354186 6480464 Sodium Selenite results in increased expression of SLC7A5 mRNA CTD PMID:24383545 dorsomorphin multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1354186 6480464 Doxorubicin results in decreased expression of SLC7A5 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1354186 6480464 Selenium results in increased expression of SLC7A5 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC7A5 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1354186 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1354186 6480464 entinostat results in increased expression of SLC7A5 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 estrone increases expression ISO RGD:1354186 6480464 Estrone results in increased expression of SLC7A5 mRNA CTD PMID:26865669 ethanol increases expression ISO RGD:733672 6480464 Ethanol results in increased expression of SLC7A5 mRNA CTD PMID:19167417 ethanol multiple interactions ISO RGD:1354186 6480464 [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC7A5 mRNA CTD PMID:29432896 ethyl methanesulfonate decreases expression ISO RGD:1354186 6480464 Ethyl Methanesulfonate results in decreased expression of SLC7A5 mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:1354186 6480464 SLC7A5 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenofibrate increases expression ISO RGD:1354186 6480464 Fenofibrate results in increased expression of SLC7A5 mRNA CTD PMID:25596134 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC7A5 mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC7A5 mRNA CTD PMID:24793618 fulvestrant decreases expression ISO RGD:1354186 6480464 fulvestrant results in decreased expression of SLC7A5 mRNA CTD PMID:26865669 furan increases methylation EXP 6480464 furan results in increased methylation of SLC7A5 gene CTD PMID:22079235 gabapentin increases import ISO RGD:1354186 6480464 SLC7A5 protein results in increased import of gabapentin CTD PMID:27818298 genistein multiple interactions ISO RGD:1354186 6480464 ESR1 promotes the reaction [Genistein results in increased expression of SLC7A5 protein] CTD PMID:20884965 genistein increases expression ISO RGD:1354186 6480464 Genistein results in increased expression of SLC7A5 mRNA, Genistein results in increased expression of SLC7A5 protein CTD PMID:15757668 more ... hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of SLC7A5 promoter CTD PMID:23740543 hydrogen peroxide decreases expression ISO RGD:1354186 6480464 Hydrogen Peroxide results in decreased expression of SLC7A5 mRNA CTD PMID:12419474 ibuprofen increases expression ISO RGD:1354186 6480464 Ibuprofen results in increased expression of SLC7A5 mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:1354186 6480464 Ifosfamide results in increased expression of SLC7A5 mRNA CTD PMID:25596134 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of SLC7A5 mRNA CTD PMID:16184411 indometacin multiple interactions ISO RGD:1354186 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SLC7A5 mRNA CTD PMID:28628672 isoniazide decreases expression ISO RGD:1354186 6480464 Isoniazid results in decreased expression of SLC7A5 mRNA CTD PMID:30008028 isotretinoin decreases expression ISO RGD:1354186 6480464 Isotretinoin results in decreased expression of SLC7A5 mRNA CTD PMID:20436886 leflunomide increases expression ISO RGD:1354186 6480464 leflunomide results in increased expression of SLC7A5 mRNA CTD PMID:28988120 mercury atom multiple interactions ISO RGD:1354186 6480464 SLC7A5 gene SNP affects the susceptibility to and affects the abundance of Mercury CTD PMID:23052037 mercury dibromide increases expression ISO RGD:1354186 6480464 mercuric bromide results in increased expression of SLC7A5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SLC7A5 mRNA CTD PMID:16507785 mercury(0) multiple interactions ISO RGD:1354186 6480464 SLC7A5 gene SNP affects the susceptibility to and affects the abundance of Mercury CTD PMID:23052037 mestranol increases expression ISO RGD:1354186 6480464 Mestranol results in increased expression of SLC7A5 mRNA CTD PMID:26865669 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC7A5 mRNA CTD PMID:25596134 methyl methanesulfonate decreases expression ISO RGD:1354186 6480464 Methyl Methanesulfonate results in decreased expression of SLC7A5 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1354186 6480464 methylmercuric chloride results in increased expression of SLC7A5 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 mitoxantrone affects response to substance ISO RGD:1354186 6480464 SLC7A5 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-acetyl-beta-D-glucosamine decreases expression ISO RGD:1354186 6480464 Acetylglucosamine results in decreased expression of SLC7A5 mRNA CTD PMID:18047607 N-acetyl-D-glucosamine decreases expression ISO RGD:1354186 6480464 Acetylglucosamine results in decreased expression of SLC7A5 mRNA CTD PMID:18047607 N-methyl-4-phenylpyridinium increases expression ISO RGD:733672 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A5 mRNA CTD PMID:22776087 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A5 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases expression ISO RGD:1354186 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A5 mRNA CTD PMID:24810058 nickel atom increases expression ISO RGD:1354186 6480464 Nickel results in increased expression of SLC7A5 mRNA CTD PMID:23195993 , PMID:25583101 nickel dichloride increases expression ISO RGD:1354186 6480464 nickel chloride results in increased expression of SLC7A5 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO RGD:1354186 6480464 nickel sulfate results in increased expression of SLC7A5 mRNA CTD PMID:16780908 more ... nicotine increases expression ISO RGD:1354186 6480464 Nicotine results in increased expression of SLC7A5 mRNA CTD PMID:23825647 ochratoxin A increases expression ISO RGD:1354186 6480464 ochratoxin A results in increased expression of SLC7A5 mRNA CTD PMID:30008028 oxaliplatin decreases expression ISO RGD:1354186 6480464 oxaliplatin results in decreased expression of SLC7A5 mRNA CTD PMID:17762391 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC7A5 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:1354186 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC7A5 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1354186 6480464 panobinostat results in increased expression of SLC7A5 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:733672 6480464 Acetaminophen affects the expression of SLC7A5 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC7A5 mRNA CTD PMID:30723492 paracetamol decreases expression ISO RGD:1354186 6480464 Acetaminophen results in decreased expression of SLC7A5 mRNA CTD PMID:26690555 paracetamol increases expression ISO RGD:1354186 6480464 Acetaminophen results in increased expression of SLC7A5 mRNA CTD PMID:21420995 more ... phenobarbital multiple interactions ISO RGD:733672 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC7A5 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:733672 6480464 Phenobarbital results in increased expression of SLC7A5 mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO RGD:1354186 6480464 Phenylmercuric Acetate results in increased expression of SLC7A5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of SLC7A5 mRNA CTD PMID:17498859 pirinixic acid multiple interactions ISO RGD:1354186 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC7A5 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:1354186 6480464 Piroxicam results in decreased expression of SLC7A5 mRNA CTD PMID:21858171 potassium bromate increases expression ISO RGD:1354186 6480464 potassium bromate results in increased expression of SLC7A5 mRNA CTD PMID:30008028 progesterone decreases expression ISO RGD:1354186 6480464 Progesterone results in decreased expression of SLC7A5 mRNA CTD PMID:18037150 quercetin increases expression ISO RGD:1354186 6480464 Quercetin results in increased expression of SLC7A5 mRNA CTD PMID:21632981 raloxifene decreases expression ISO RGD:1354186 6480464 Raloxifene Hydrochloride results in decreased expression of SLC7A5 mRNA CTD PMID:26865669 resveratrol multiple interactions ISO RGD:1354186 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SLC7A5 mRNA CTD PMID:19167446 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of SLC7A5 mRNA CTD PMID:18047727 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC7A5 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1354186 6480464 Selenium results in increased expression of SLC7A5 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1354186 6480464 Silicon Dioxide analog results in increased expression of SLC7A5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:733672 6480464 Silicon Dioxide results in increased expression of SLC7A5 mRNA CTD PMID:23221170 sodium arsenite increases expression ISO RGD:1354186 6480464 sodium arsenite results in increased expression of SLC7A5 mRNA CTD PMID:12760830 , PMID:29301061 tamoxifen decreases expression ISO RGD:1354186 6480464 Tamoxifen results in decreased expression of SLC7A5 mRNA CTD PMID:19155303 tert-butyl hydroperoxide decreases expression ISO RGD:1354186 6480464 tert-Butylhydroperoxide results in decreased expression of SLC7A5 mRNA CTD PMID:12419474 tetraphene increases expression ISO RGD:1354186 6480464 benz(a)anthracene results in increased expression of SLC7A5 mRNA CTD PMID:26621329 thapsigargin increases expression ISO RGD:1354186 6480464 Thapsigargin results in increased expression of SLC7A5 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC7A5 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:733672 6480464 titanium dioxide results in decreased expression of SLC7A5 mRNA CTD PMID:29264374 titanium dioxide multiple interactions ISO RGD:733672 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC7A5 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC7A5 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC7A5 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of SLC7A5 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1354186 6480464 trichostatin A results in increased expression of SLC7A5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 tunicamycin increases expression ISO RGD:1354186 6480464 Tunicamycin results in increased expression of SLC7A5 mRNA CTD PMID:22378314 , PMID:29453283 valproic acid increases methylation ISO RGD:1354186 6480464 Valproic Acid results in increased methylation of SLC7A5 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1354186 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1354186 6480464 Valproic Acid results in increased expression of SLC7A5 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC7A5 mRNA CTD PMID:23034163 zearalenone increases expression ISO RGD:1354186 6480464 Zearalenone results in increased expression of SLC7A5 mRNA CTD PMID:19371625 zidovudine increases expression ISO RGD:1354186 6480464 Zidovudine results in increased expression of SLC7A5 mRNA CTD PMID:24292225 zoledronic acid decreases expression ISO RGD:1354186 6480464 zoledronic acid results in decreased expression of SLC7A5 mRNA CTD PMID:24714768 , PMID:25596134
Gene-Chemical Interaction Annotations
